未成熟血小板分数预测登革热血小板恢复轨迹
第1天IPF较高者血小板恢复更快(p<0.0001);高IPF组第5天持续下降比例低于低IPF组(28.6% vs 47.8%;Kruskal-Wallis p=0.013)。
要点
- 登革热患者第1天IPF可预测后续血小板恢复速度
- 高IPF组第5天血小板持续下降比例低于低IPF组
- 血小板计数从118降至98×10^9/L,IPF从9.7%升至12.9%
核心结论
- IPF是预测登革热血小板恢复轨迹的动态生物标志物。
主要发现
- 血小板计数从118降至98×10^9/L(p=0.0017),IPF从9.7%升至12.9%(p<0.0001)。
- 基线IPF较高预测血小板恢复更快(p<0.0001)。
- 高IPF组第5天持续血小板下降比例低于低IPF组(28.6% vs 47.8%;Kruskal-Wallis p=0.013)。
临床怎么用
- 临床可检测第1天IPF辅助判断登革热血小板恢复趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dengue commonly causes thrombocytopenia, but platelet count alone may not reflect marrow thrombopoiesis. Immature platelet fraction (IPF) is a potential marker of platelet regeneration, though longitudinal data are limited. We thus aimed to evaluate whether Day 1 IPF predicts subsequent platelet recovery trajectory and to describe longitudinal trends in clinical, biochemical and platelet indices. This was a retrospective longitudinal analytical study conducted at a tertiary care hospital in Western Maharashtra, India. Six hundred and sixty-seven patients with confirmed dengue, with platelet count, IPF and World Health Organization (WHO) classification recorded on Day 1, with follow-up at Day 3 and 5. Log-transformed platelet counts at Day 3 and Day 5 were analysed using generalized least squares regression. Longitudinal changes were assessed using the Friedman test. Median age was 31 years, with 81.4% males. Platelet counts declined from 118 to 98 × 109/L (p = 0.0017), while IPF increased from 9.7% to 12.9% (p < 0.0001). Higher baseline IPF predicted faster platelet recovery (p < 0.0001). Continued platelet decline at Day 5 was lower in the high-IPF group than the low-IPF group (28.6% vs. 47.8%; Kruskal-Wallis p = 0.013). We thus conclude that IPF is a dynamic biomarker that predicts platelet recovery trajectory in dengue.
引用
- Singh SK, Kumar S, Sreejith PV, et al. Immature platelet fraction predicts differential platelet recovery trajectories in dengue fever: A longitudinal analysis. Br J Haematol. 2026. PMID: 42504060. doi:10.1111/bjh.70719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。